Asthma, pneumonia and over 20 other conditions affecting the lungs and respiratory system are supported by PIP.

A single charge lasts for 35 minutes of use, and the unit only needs to be recharged once every two days. Pharmacy students ...

Explore the latest research on Aspergillus in bronchiectasis, uncovering its prevalence, clinical significance, and potential ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into the development process of new therapies for COPD, according to a new ...

November has been a good month on the new Disney Plus movies front. Admittedly, the streamer has only added five new movies – including this week's two entries – to its back catalog this month ...

The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The latest comprehensive report on Non-cystic Fibrosis Bronchiectasis (NCFB ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and lead to the first leap in treatment for 50 years, researchers have said.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low ...

By Dr. Priyom Bose, Ph.D.Reviewed by Benedette Cuffari, M.Sc.Nov 26 2024 New research underscores how air pollution and temperature extremes amplify risks for bronchiectasis patients, pointing to ...